| Bioactivity | Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD)[1]. |
| Target | IC50: 29.3 ± 1.8 μM (Glucocerebrosidase) |
| Invitro | Glucocerebrosidase-IN-1 (compound 11a) is able to enhance GCase activity 1.8-fold in fibroblasts bearing the homozygous L444P mutation[1]. |
| Name | Glucocerebrosidase-IN-1 |
| CAS | 2279945-76-3 |
| Formula | C13H27NO3 |
| Molar Mass | 245.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Clemente F, et al. Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoning. Bioorg Chem. 2020 May;98:103740. |
Glucocerebrosidase-IN-1
CAS: 2279945-76-3 F: C13H27NO3 W: 245.36
Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.